OncoBone Ventures presented in Qiagen Innovation Forum 2022

OncoBone Ventures and its fully owned subsidiary OncoBone Therapeutics presented in Qiagen Innovation Forum 2022. The presentation was given as a continuation to Qiagen’s Biotech Grant Competition where OncoBone Therapeutics was selected as the winner in 2021. For more information, see the following news where the grant winners are announced.

The presentation was titled ‘Developing novel therapies for cancer bone metastasis – an unmet medical need’. You can watch the recorded presentation from the following link.

CSO of OncoBone Ventures, Tiina Kähkönen comments: ‘We are grateful for Qiagen for selecting us as the Biotech Grant winner and for the opportunity to present in the Innovation Forum. The presentation provided us an excellent opportunity to present our current and future developments in the field of cancer bone metastasis drug development’.